Since chronic low-grade inflammation is associated with T2DM (Kohn et al., 2005), one of its markers, C-reactive protein (CRP), is frequently investigated as an intermediate phenotype that increases the risk of T2DM. This evidence concerns the gene CRP and type 2 diabetes mellitus.